Mucin Binding to Moraxella catarrhalis during Airway Inflammation Is Dependent on Sialic Acid

Chronic obstructive pulmonary disease (COPD) is associated with colonization by bacterial pathogens and repeated airway infections, leading to exacerbations and impaired lung function. The highly glycosylated mucins in the mucus lining the airways are an important part of the host defense against pa...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory cell and molecular biology Vol. 65; no. 6; pp. 593 - 602
Main Authors Padra, Médea, Benktander, John, Padra, János T., Andersson, Anders, Brundin, Bettina, Tengvall, Sara, Christenson, Karin, Qvarfordt, Ingemar, Gad, Robert, Paulsson, Magnus, Pournaras, Nikolaos, Lindén, Anders, Lindén, Sara K.
Format Journal Article
LanguageEnglish
Published United States American Thoracic Society 01.12.2021
Subjects
Online AccessGet full text
ISSN1044-1549
1535-4989
1535-4989
DOI10.1165/rcmb.2021-0064OC

Cover

Abstract Chronic obstructive pulmonary disease (COPD) is associated with colonization by bacterial pathogens and repeated airway infections, leading to exacerbations and impaired lung function. The highly glycosylated mucins in the mucus lining the airways are an important part of the host defense against pathogens. However, mucus accumulation can contribute to COPD pathology. Here, we examined whether inflammation is associated with glycosylation changes that affect interactions between airway mucins and pathogens. We isolated mucins from lower airway samples (  = 4-9) from long-term smokers with and without COPD and from never-smokers. The most abundant terminal glycan moiety was -acetylneuraminic acid (Neu5Ac) among smokers with and without COPD and -acetyl-hexoseamine among never-smokers. bound to MUC5 mucins from smokers with and without COPD. binding correlated with inflammatory parameters and Neu5Ac content. binding was abolished by enzymatic removal of Neu5Ac. Furthermore, bound to α2,6 sialyl-lactose, suggesting that α2,6 sialic acid contributes to binding to mucins. Furthermore, we detected more binding to mucins from patients with pneumonia than to those from control subjects (  = 8-13), and this binding correlated with C-reactive protein and Neu5Ac levels. These results suggest a key role of inflammation-induced Neu5Ac in the adhesion of to airway mucins. The inflammation-induced ability of MUC5 mucins to bind is likely a host defense mechanism in the healthy lung, although it cannot be excluded that impaired mucociliary clearance limits the effectiveness of this defense in patients with COPD.
AbstractList Chronic obstructive pulmonary disease (COPD) is associated with colonization by bacterial pathogens and repeated airway infections, leading to exacerbations and impaired lung function. The highly glycosylated mucins in the mucus lining the airways are an important part of the host defense against pathogens. However, mucus accumulation can contribute to COPD pathology. Here, we examined whether inflammation is associated with glycosylation changes that affect interactions between airway mucins and pathogens. We isolated mucins from lower airway samples (n = 4-9) from long-term smokers with and without COPD and from never-smokers. The most abundant terminal glycan moiety was N-acetylneuraminic acid (Neu5Ac) among smokers with and without COPD and N-acetyl-hexoseamine among never-smokers. Moraxella catarrhalis bound to MUC5 mucins from smokers with and without COPD. M. catarrhalis binding correlated with inflammatory parameters and Neu5Ac content. M. catarrhalis binding was abolished by enzymatic removal of Neu5Ac. Furthermore, M. catarrhalis bound to α2,6 sialyl-lactose, suggesting that α2,6 sialic acid contributes to M. catarrhalis binding to mucins. Furthermore, we detected more M. catarrhalis binding to mucins from patients with pneumonia than to those from control subjects (n = 8-13), and this binding correlated with C-reactive protein and Neu5Ac levels. These results suggest a key role of inflammation-induced Neu5Ac in the adhesion of M. catarrhalis to airway mucins. The inflammation-induced ability of MUC5 mucins to bind M. catarrhalis is likely a host defense mechanism in the healthy lung, although it cannot be excluded that impaired mucociliary clearance limits the effectiveness of this defense in patients with COPD.Chronic obstructive pulmonary disease (COPD) is associated with colonization by bacterial pathogens and repeated airway infections, leading to exacerbations and impaired lung function. The highly glycosylated mucins in the mucus lining the airways are an important part of the host defense against pathogens. However, mucus accumulation can contribute to COPD pathology. Here, we examined whether inflammation is associated with glycosylation changes that affect interactions between airway mucins and pathogens. We isolated mucins from lower airway samples (n = 4-9) from long-term smokers with and without COPD and from never-smokers. The most abundant terminal glycan moiety was N-acetylneuraminic acid (Neu5Ac) among smokers with and without COPD and N-acetyl-hexoseamine among never-smokers. Moraxella catarrhalis bound to MUC5 mucins from smokers with and without COPD. M. catarrhalis binding correlated with inflammatory parameters and Neu5Ac content. M. catarrhalis binding was abolished by enzymatic removal of Neu5Ac. Furthermore, M. catarrhalis bound to α2,6 sialyl-lactose, suggesting that α2,6 sialic acid contributes to M. catarrhalis binding to mucins. Furthermore, we detected more M. catarrhalis binding to mucins from patients with pneumonia than to those from control subjects (n = 8-13), and this binding correlated with C-reactive protein and Neu5Ac levels. These results suggest a key role of inflammation-induced Neu5Ac in the adhesion of M. catarrhalis to airway mucins. The inflammation-induced ability of MUC5 mucins to bind M. catarrhalis is likely a host defense mechanism in the healthy lung, although it cannot be excluded that impaired mucociliary clearance limits the effectiveness of this defense in patients with COPD.
Chronic obstructive pulmonary disease (COPD) is associated with colonization by bacterial pathogens and repeated airway infections, leading to exacerbations and impaired lung function. The highly glycosylated mucins in the mucus lining the airways are an important part of the host defense against pathogens. However, mucus accumulation can contribute to COPD pathology. Here, we examined whether inflammation is associated with glycosylation changes that affect interactions between airway mucins and pathogens. We isolated mucins from lower airway samples (LAS, n=4-9) from long-term smokers with and without COPD and from never-smokers. The most abundant terminal glycan moiety was N-acetylneuraminic acid (Neu5Ac) among smokers with and without COPD and N-acetyl-hexoseamine among never-smokers. Moraxella catarrhalis bound to MUC5 mucins from smokers with and without COPD. M. catarrhalis binding correlated with inflammatory parameters and Neu5Ac content. M. catarrhalis binding was abolished by enzymatic removal of Neu5Ac. Furthermore, M. catarrhalis bound to α2-6 sialyl-lactose suggesting that α2-6 sialic acid contributes to M. catarrhalis binding to mucins. Further, we detected more M. catarrhalis binding to mucins from patients with pneumonia than to those from control subjects (n=8-13) and this binding correlated with C-reactive protein and Neu5Ac levels. These results suggest a key role of inflammation induced Neu5Ac in adhesion of M. catarrhalis to airway mucins. Inflammation induced ability of MUC5 mucins to bind M. catarrhalis is likely a host defense mechanism in the healthy lung, although it cannot be excluded that impaired mucociliary clearance limits the effectiveness of this defense in COPD patients.
Chronic obstructive pulmonary disease (COPD) is associated with colonization by bacterial pathogens and repeated airway infections, leading to exacerbations and impaired lung function. The highly glycosylated mucins in the mucus lining the airways are an important part of the host defense against pathogens. However, mucus accumulation can contribute to COPD pathology. Here, we examined whether inflammation is associated with glycosylation changes that affect interactions between airway mucins and pathogens. We isolated mucins from lower airway samples (  = 4-9) from long-term smokers with and without COPD and from never-smokers. The most abundant terminal glycan moiety was -acetylneuraminic acid (Neu5Ac) among smokers with and without COPD and -acetyl-hexoseamine among never-smokers. bound to MUC5 mucins from smokers with and without COPD. binding correlated with inflammatory parameters and Neu5Ac content. binding was abolished by enzymatic removal of Neu5Ac. Furthermore, bound to α2,6 sialyl-lactose, suggesting that α2,6 sialic acid contributes to binding to mucins. Furthermore, we detected more binding to mucins from patients with pneumonia than to those from control subjects (  = 8-13), and this binding correlated with C-reactive protein and Neu5Ac levels. These results suggest a key role of inflammation-induced Neu5Ac in the adhesion of to airway mucins. The inflammation-induced ability of MUC5 mucins to bind is likely a host defense mechanism in the healthy lung, although it cannot be excluded that impaired mucociliary clearance limits the effectiveness of this defense in patients with COPD.
Chronic obstructive pulmonary disease (COPD) is associated with colonization by bacterial pathogens and repeated airway infections, leading to exacerbations and impaired lung function. The highly glycosylated mucins in the mucus lining the airways are an important part of the host defense against pathogens. However, mucus accumulation can contribute to COPD pathology. Here, we examined whether inflammation is associated with glycosylation changes that affect interactions between airway mucins and pathogens. We isolated mucins from lower airway samples (n = 4-9) from long-term smokers with and without COPD and from never-smokers. The most abundant terminal glycan moiety was N-acetylneuraminic acid (Neu5Ac) among smokers with and without COPD and N-acetyl-hexoseamine among never-smokers. Moraxella catarrhalis bound to MUC5 mucins from smokers with and without COPD. M. catarrhalis binding correlated with inflammatory parameters and Neu5Ac content. M. catarrhalis binding was abolished by enzymatic removal of Neu5Ac. Furthermore, M. catarrhalis bound to a2,6 sialyl-lactose, suggesting that a2,6 sialic acid contributes to M. catarrhalis binding to mucins. Furthermore, we detected more M. catarrhalis binding to mucins from patients with pneumonia than to those from control subjects (n = 8-13), and this binding correlated with C-reactive protein and Neu5Ac levels. These results suggest a key role of inflammation-induced Neu5Ac in the adhesion of M. catarrhalis to airway mucins. The inflammation-induced ability of MUC5 mucins to bind M. catarrhalis is likely a host defense mechanism in the healthy lung, although it cannot be excluded that impaired mucociliary clearance limits the effectiveness of this defense in patients with COPD.
Author Padra, János T.
Christenson, Karin
Pournaras, Nikolaos
Benktander, John
Andersson, Anders
Gad, Robert
Qvarfordt, Ingemar
Padra, Médea
Lindén, Sara K.
Brundin, Bettina
Lindén, Anders
Paulsson, Magnus
Tengvall, Sara
Author_xml – sequence: 1
  givenname: Médea
  surname: Padra
  fullname: Padra, Médea
  organization: Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine
– sequence: 2
  givenname: John
  surname: Benktander
  fullname: Benktander, John
  organization: Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine
– sequence: 3
  givenname: János T.
  surname: Padra
  fullname: Padra, János T.
  organization: Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine
– sequence: 4
  givenname: Anders
  surname: Andersson
  fullname: Andersson, Anders
  organization: Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, and, COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden
– sequence: 5
  givenname: Bettina
  surname: Brundin
  fullname: Brundin, Bettina
  organization: Unit for Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
– sequence: 6
  givenname: Sara
  surname: Tengvall
  fullname: Tengvall, Sara
  organization: Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, and
– sequence: 7
  givenname: Karin
  surname: Christenson
  fullname: Christenson, Karin
  organization: Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
– sequence: 8
  givenname: Ingemar
  surname: Qvarfordt
  fullname: Qvarfordt, Ingemar
  organization: Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, and
– sequence: 9
  givenname: Robert
  surname: Gad
  fullname: Gad, Robert
  organization: Department of Anesthesiology and Intensive Care, and
– sequence: 10
  givenname: Magnus
  surname: Paulsson
  fullname: Paulsson, Magnus
  organization: Department of Infectious Diseases, Skåne University Hospital, Lund; Sweden;, Translational Infection Medicine, Lund University, Lund, Sweden; and
– sequence: 11
  givenname: Nikolaos
  surname: Pournaras
  fullname: Pournaras, Nikolaos
  organization: Unit for Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;, Karolinska Severe COPD Center, Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden
– sequence: 12
  givenname: Anders
  surname: Lindén
  fullname: Lindén, Anders
  organization: Unit for Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;, Karolinska Severe COPD Center, Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden
– sequence: 13
  givenname: Sara K.
  orcidid: 0000-0002-7751-9586
  surname: Lindén
  fullname: Lindén, Sara K.
  organization: Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34192508$$D View this record in MEDLINE/PubMed
https://gup.ub.gu.se/publication/306201$$DView record from Swedish Publication Index
http://kipublications.ki.se/Default.aspx?queryparsed=id:148312270$$DView record from Swedish Publication Index
BookMark eNp9kstv1DAQhyNURB9w54QiceGS4vEr8XFZKKzUqgfgiKyJ42xdEifYiUr_-zq7Sw-Vysnj8fcbz-s0O_KDt1n2Fsg5gBQfg-nrc0ooFIRIfr1-kZ2AYKLgqlJHySacFyC4Os5OY7wlBGgF8Co7ZhwUFaQ6yX5dzcb5_JPzjfPbfBryqyHgX9t1mBucMIQb7FzMmzks7ysX7vA-3_i2w77HyQ0-38T8sx2tb6yf8nT_7pLC5CvjmtfZyxa7aN8czrPs58WXH-tvxeX11816dVkYrthUCNMwwVlKuuaS1SUntJYoFZZMEVQIyU9tW5JWKlFX1GArZClQyBalrBp2lhX7uPHOjnOtx-B6DPd6QKcPrt_JsppLoghNPD7Lj0OYsNPBRovB3OhuXoSJSkXtCo5acsk5V6hLwonmgFIjGqMBILmB06aE_-a0nUedXNtdaEYkJQv_Yc-PYfgz2zjp3kWzDMLbYY6aCl4KBunnhL5_gt4Oc_Cpw5qmAgGEICxR7w7UXPe2eUzg3_ATQPaACUOMwbaPCBC97Jde9ksv-6X3-5Uk8onEuGnXlSmg654XPgBy1NUj
CitedBy_id crossref_primary_10_1038_s41467_024_50198_z
crossref_primary_10_1016_j_carbpol_2024_122471
crossref_primary_10_1099_mic_0_001157
crossref_primary_10_1186_s40168_023_01528_8
crossref_primary_10_1093_glycob_cwad071
crossref_primary_10_1186_s12931_023_02576_2
crossref_primary_10_1186_s40168_022_01402_z
Cites_doi 10.1042/bj3340685
10.1172/jci.insight.120994
10.1021/acs.jproteome.8b00973
10.1128/IAI.00189-17
10.1038/s41385-019-0154-4
10.1128/IAI.73.8.4653-4667.2005
10.1371/journal.ppat.1000617
10.5694/j.1326-5377.1989.tb101168.x
10.1111/j.1574-6968.1996.tb08005.x
10.1111/omi.12113
10.1042/BJ20040402
10.1016/j.bbrc.2017.08.113
10.1128/IAI.01475-06
10.1164/rccm.201603-0526LE
10.1164/rccm.200803-391OC
10.1111/j.1523-5378.2010.00765.x
10.1371/journal.pone.0015216
10.1084/jem.158.2.559
10.1042/bj3180319
10.1165/ajrcmb.15.2.8703480
10.1093/glycob/cwm036
10.1371/journal.pone.0036378
10.1038/srep40656
10.1111/j.1365-2958.2005.04984.x
10.1038/s41598-017-17850-9
10.1073/pnas.85.16.6157
10.1128/iai.59.4.1325-1333.1991
10.1002/9780470035399.ch13
10.1007/BF00702348
10.1164/ajrccm.164.supplement_2.2106067
10.1042/bj3610537
10.1371/journal.ppat.1003223
10.1378/chest.127.6.2072
10.1038/mi.2008.5
10.1042/CS20191085
10.1371/journal.ppat.0040002
10.1056/NEJMoa1701632
10.1136/thx.42.11.843
10.1152/ajplung.00108.2004
10.1042/BJ20041641
10.1128/IAI.68.2.921-924.2000
10.1080/21505594.2018.1460979
10.1159/000056500
10.1042/BST20170402
ContentType Journal Article
Copyright Copyright American Thoracic Society Dec 2021
Copyright_xml – notice: Copyright American Thoracic Society Dec 2021
CorporateAuthor Clinical Microbiology, Malmö
Klinisk mikrobiologi, Malmö
Faculty of Medicine
Institutionen för translationell medicin
Department of Translational Medicine
Lunds universitet
Medicinska fakulteten
Lund University
CorporateAuthor_xml – name: Faculty of Medicine
– name: Medicinska fakulteten
– name: Klinisk mikrobiologi, Malmö
– name: Clinical Microbiology, Malmö
– name: Lund University
– name: Department of Translational Medicine
– name: Lunds universitet
– name: Institutionen för translationell medicin
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
H94
K9.
7X8
ADTPV
AOWAS
F1U
D95
DOI 10.1165/rcmb.2021-0064OC
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
SwePub
SwePub Articles
SWEPUB Göteborgs universitet
SWEPUB Lunds universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1535-4989
EndPage 602
ExternalDocumentID oai_swepub_ki_se_460902
oai_portal_research_lu_se_publications_6464449a_7040_41a6_aacc_111449142d71
oai_gup_ub_gu_se_306201
34192508
10_1165_rcmb_2021_0064OC
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
23M
2WC
53G
5GY
5RE
7X7
88E
88I
8AF
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AAYXX
ABJNI
ABUWG
ACGFO
ACGFS
ACGOD
ACPRK
ADBBV
AENEX
AFFNX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBNVY
BENPR
BES
BHPHI
BPHCQ
BVXVI
C45
CCPQU
CITATION
CS3
DIK
DWQXO
E3Z
EBS
EJD
EMOBN
F5P
FYUFA
GNUQQ
GX1
H13
HCIFZ
HMCUK
HZ~
J5H
LK8
M1P
M2P
M2Q
M5~
M7P
O9-
OBH
OFXIZ
OK1
OVD
OVIDX
P2P
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PZZ
Q2X
RWL
S0X
SJN
TAE
TEORI
THO
TR2
UKHRP
W8F
WOQ
YHG
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
H94
K9.
7X8
ADTPV
AOWAS
F1U
PJZUB
PPXIY
PQGLB
PUEGO
D95
ID FETCH-LOGICAL-c493t-5cd3543989b463b7402b6a69a7390a9a19b42ef70f695b82caf5675a56fa668d3
ISSN 1044-1549
1535-4989
IngestDate Wed Sep 24 03:40:02 EDT 2025
Tue Sep 09 23:36:18 EDT 2025
Wed Sep 10 03:08:46 EDT 2025
Thu Sep 04 16:37:39 EDT 2025
Mon Jun 30 10:10:25 EDT 2025
Thu Apr 03 07:10:16 EDT 2025
Tue Jul 01 03:31:38 EDT 2025
Thu Apr 24 22:53:49 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Moraxella catarrhalis
sialic acid
mucin
host–pathogen interaction
COPD
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c493t-5cd3543989b463b7402b6a69a7390a9a19b42ef70f695b82caf5675a56fa668d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7751-9586
PMID 34192508
PQID 2609115503
PQPubID 2031371
PageCount 10
ParticipantIDs swepub_primary_oai_swepub_ki_se_460902
swepub_primary_oai_portal_research_lu_se_publications_6464449a_7040_41a6_aacc_111449142d71
swepub_primary_oai_gup_ub_gu_se_306201
proquest_miscellaneous_2547531644
proquest_journals_2609115503
pubmed_primary_34192508
crossref_primary_10_1165_rcmb_2021_0064OC
crossref_citationtrail_10_1165_rcmb_2021_0064OC
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-01
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle American journal of respiratory cell and molecular biology
PublicationTitleAlternate Am J Respir Cell Mol Biol
PublicationYear 2021
Publisher American Thoracic Society
Publisher_xml – name: American Thoracic Society
References Sheehan JK (bib27) 2006; 279
Umehara T (bib6) 2011; 183
bib14
bib36
bib15
bib37
bib34
bib35
bib10
bib32
bib11
bib33
bib30
bib31
bib29
bib28
Wright PW (bib12) 1989; 4
bib40
bib25
bib47
bib26
bib23
bib45
bib24
bib46
bib21
bib43
bib22
bib44
bib41
bib20
bib42
bib9
Bernstein JM (bib13) 2000; 122
bib7
bib8
bib5
bib18
bib19
bib3
bib16
bib38
bib4
bib17
bib39
bib1
bib2
References_xml – ident: bib20
  doi: 10.1042/bj3340685
– ident: bib3
  doi: 10.1172/jci.insight.120994
– ident: bib47
  doi: 10.1021/acs.jproteome.8b00973
– ident: bib37
  doi: 10.1128/IAI.00189-17
– ident: bib42
  doi: 10.1038/s41385-019-0154-4
– ident: bib44
  doi: 10.1128/IAI.73.8.4653-4667.2005
– ident: bib5
  doi: 10.1371/journal.ppat.1000617
– ident: bib11
  doi: 10.5694/j.1326-5377.1989.tb101168.x
– ident: bib14
  doi: 10.1111/j.1574-6968.1996.tb08005.x
– ident: bib16
  doi: 10.1111/omi.12113
– ident: bib22
  doi: 10.1042/BJ20040402
– ident: bib39
  doi: 10.1016/j.bbrc.2017.08.113
– ident: bib46
  doi: 10.1128/IAI.01475-06
– ident: bib28
  doi: 10.1164/rccm.201603-0526LE
– ident: bib30
  doi: 10.1164/rccm.200803-391OC
– ident: bib31
  doi: 10.1111/j.1523-5378.2010.00765.x
– ident: bib32
  doi: 10.1371/journal.pone.0015216
– volume: 4
  start-page: 40
  year: 1989
  ident: bib12
  publication-title: Semin Respir Infect
– volume: 183
  start-page: A1394
  year: 2011
  ident: bib6
  publication-title: Am J Respir Crit Care Med
– ident: bib35
  doi: 10.1084/jem.158.2.559
– volume: 122
  start-page: 514
  year: 2000
  ident: bib13
  publication-title: Otolaryngol Head Neck Surg
– ident: bib25
  doi: 10.1042/bj3180319
– ident: bib26
  doi: 10.1165/ajrcmb.15.2.8703480
– ident: bib10
  doi: 10.1093/glycob/cwm036
– ident: bib18
  doi: 10.1371/journal.pone.0036378
– ident: bib41
  doi: 10.1038/srep40656
– ident: bib43
  doi: 10.1111/j.1365-2958.2005.04984.x
– ident: bib15
  doi: 10.1038/s41598-017-17850-9
– ident: bib34
  doi: 10.1073/pnas.85.16.6157
– ident: bib45
  doi: 10.1128/iai.59.4.1325-1333.1991
– volume: 279
  start-page: 155
  year: 2006
  ident: bib27
  publication-title: Novartis Found Symp
  doi: 10.1002/9780470035399.ch13
– ident: bib19
  doi: 10.1007/BF00702348
– ident: bib23
  doi: 10.1164/ajrccm.164.supplement_2.2106067
– ident: bib29
  doi: 10.1042/bj3610537
– ident: bib8
  doi: 10.1371/journal.ppat.1003223
– ident: bib33
  doi: 10.1378/chest.127.6.2072
– ident: bib1
  doi: 10.1038/mi.2008.5
– ident: bib4
  doi: 10.1042/CS20191085
– ident: bib38
  doi: 10.1371/journal.ppat.0040002
– ident: bib2
  doi: 10.1056/NEJMoa1701632
– ident: bib24
  doi: 10.1136/thx.42.11.843
– ident: bib9
  doi: 10.1152/ajplung.00108.2004
– ident: bib7
  doi: 10.1042/BJ20041641
– ident: bib36
  doi: 10.1128/IAI.68.2.921-924.2000
– ident: bib17
  doi: 10.1080/21505594.2018.1460979
– ident: bib21
  doi: 10.1159/000056500
– ident: bib40
  doi: 10.1042/BST20170402
SSID ssj0012811
Score 2.4105043
Snippet Chronic obstructive pulmonary disease (COPD) is associated with colonization by bacterial pathogens and repeated airway infections, leading to exacerbations...
SourceID swepub
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 593
SubjectTerms Airway management
Basic Medicine
C-reactive protein
Chronic obstructive pulmonary disease
Clinical Medicine
COPD
Cytokines
Glycosylation
host–pathogen interaction
Humans
Immunologi inom det medicinska området
Immunologi inom det medicinska området (Här ingår: Cell- och immunterapi)
Immunology in the Medical Area
Immunology in the Medical Area (including Cell and Immunotherapy)
Inflammation
Klinisk medicin
Lactose
Lung - metabolism
Lung - microbiology
Lung diseases
Lungmedicin och allergi
Medical and Health Sciences
Medicin och hälsovetenskap
Medicinska och farmaceutiska grundvetenskaper
Microbiology in the Medical Area
Mikrobiologi inom det medicinska området
Moraxella catarrhalis
Moraxella catarrhalis - metabolism
Mucin
Mucin-5B - metabolism
Mucus
N-Acetylneuraminic acid
Obstructive lung disease
Pathogens
Pulmonary Disease, Chronic Obstructive - metabolism
Pulmonary Disease, Chronic Obstructive - microbiology
Respiratory function
Respiratory Medicine and Allergy
Respiratory Mucosa - metabolism
Respiratory Mucosa - microbiology
Respiratory tract
Respiratory tract diseases
sialic acid
Sialic Acids - metabolism
Title Mucin Binding to Moraxella catarrhalis during Airway Inflammation Is Dependent on Sialic Acid
URI https://www.ncbi.nlm.nih.gov/pubmed/34192508
https://www.proquest.com/docview/2609115503
https://www.proquest.com/docview/2547531644
https://gup.ub.gu.se/publication/306201
http://kipublications.ki.se/Default.aspx?queryparsed=id:148312270
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZCmMvY2t3ydYNDUZhhKSxLcv2YzpS2tJ0Y0sgDIaQZLs1bZyQOGzdX9if3tEljpOG0e3FxLJky_mOjs_RuSH03iHAeSPutSQNQUEBhtcKBSx3QQWNZRgLVzuP9y_oyZCcjfxRrfa74rW0KERb_toaV_I_qEIb4KqiZP8B2fKm0AC_AV84AsJwvBfG_YXM8uZRZiJTQIrsA6A_lT9TU23LzGZXKr3hMhSxm81-8FvgCClQgYlYbJ7OgeOYMriFsht8hUlnstmV2VoBz9KuU0k0MasY6dX2vzZDjJfVdps2u9PKRBXrikbNvjHNx8lqJyDJrwsdZLPpG1wOOtODnHwyXzl1d3VYjg0YMyfVLQzXqbiDLLmu3yKRqSXUTra0WVZtykpYkqzyXd-UWbz7PaAqdcZMjkVbP1hJYDZZ5lrq7YtP7Hh4fs4GvdHgAdpxAxDE6mjnqHfx-UtplHJDx6bfNTNbWr2pf7j5hHUp547qspGXVssygyfosVVCcNdQ1FNUS_JdtNfNAczxLT7A2i1Yw7eLHvat98Ue-q7pDVt6w8UEl_SGK_SGDb1hQ2-4Sm_4dI5LesNwbugNK3p7hobHvcHHk5Ytz9GSJPKKli9jzwd5NowEoZ4ISMcVlNOIB17U4RF3oN1N0qCT0sgXoSt56oN6yn2ackrD2HuO6vkkT14iTAX0lTL13DQkqRcJmQZE8MgNQvUVlA10uPw7mbS561UJlRumdVjqMwUAUwAwA0ADfShHTE3elr_03V8ixOwymjPQ80EOAP3da6B35WXgvWpF8TyZLKCPT0Dbd0ClaKAXBtnyYSpPIqgXYQMdGKjLKyqh--ViyqDpcsHmCQOtHcTwBvq2paNRwpnN_HXFbvSIaWVLn1ECEyARZwF8kBlxOGWcS6l0e2h2iBsHzvZZ2KbrTN2TUOWi_eoeL_saPVqt4n1UL2aL5A2I5oV4a5fMH1nX5_U
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mucin+Binding+to+Moraxella+catarrhalis+during+Airway+Inflammation+Is+Dependent+on+Sialic+Acid&rft.jtitle=American+journal+of+respiratory+cell+and+molecular+biology&rft.au=Padra%2C+M%C3%A9dea&rft.au=Benktander%2C+John&rft.au=Padra%2C+J%C3%A1nos+T&rft.au=Andersson%2C+Anders&rft.date=2021-12-01&rft.issn=1535-4989&rft.eissn=1535-4989&rft.volume=65&rft.issue=6&rft.spage=593&rft_id=info:doi/10.1165%2Frcmb.2021-0064OC&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1044-1549&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1044-1549&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1044-1549&client=summon